RVL Pharmaceuticals Subsidiaries File For Bankruptcy
Wall Street Journal
Prepackaged deal with lender Athyrium Capital and other key stakeholders will enable the subsidiaries to reduce debt, streamline operations and position themselves under new ownership.
https://www.wsj.com/articles/rvl-pharmaceuticals-subsidiaries-file-for-bankruptcy-ce268557